Anticoagulants Improve Survival Rates in Patients With COVID-19

June 01, 2020

Researchers from the Mount Sinai COVID Informatics Center report improved survival rates in COVID patients treated with anticoagulants.

Time of Day for Taking Warfarin Does Not Affect Anticoagulation Stability

January 27, 2020

Administration time for warfarin did not affect the stability of the drug’s anticoagulation effect, a new study showed. 

Crizanlizumab for Sickle Cell Pain Reduction Approved by FDA

November 15, 2019

First and currently only biological targeting P-selectin.

Wilate Approved for Hemophilia A Treatment

October 09, 2019

Also indciated to control bleeding and perioperative management.

New Warnings for Tofacitinib Issued by FDA

July 29, 2019

Black box warns of increased risk of blood clots and death.

Study: VKAs Better Protect Aortic Valve Replacement Patients

June 14, 2019

Study finds higher Ischemic events and mortality in transcatheter valve replacement patients taking non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists.

AF Patients Taking OACs Have Lower Dementia Risk

June 14, 2019

Low-risk atrial fibrillation patients who take oral anticoagulants have a lower risk of dementia than those who do not, a study says.

DOAC Use Increasing in Nursing Homes

May 24, 2019

The use of direct‐acting oral anticoagulants has increased among nursing home residents with atrial fibrillation.

Atrial Fibrillation Patients Often Overestimate Stroke and Bleeding Risks

May 24, 2019

Overestimating the bleeding risk of anticoagulants may lead to poor compliance.

FDA Approves Fragmin as First Pediatric Anticoagulant Treatment

May 16, 2019

Fragmin, a low-molecular-weight heparin dalteparin sodium injection, was approved for symptomatic venous thromboembolism.